Eloxx Pharmaceuticals, Inc.·4

Oct 17, 4:02 PM ET

Walts Alan Edmund 4

4 · Eloxx Pharmaceuticals, Inc. · Filed Oct 17, 2024

Insider Transaction Report

Form 4
Period: 2024-10-16
Transactions
  • Award

    Common Stock

    2024-10-16+12,00012,942 total
Footnotes (1)
  • [F1]This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Documents

1 file
  • 4
    tm2426349-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT